Piloting an Insomnia Treatment in Patients With Ulcerative Colitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDartmouth-Hitchcock Medical Center

About this trial

The goal of this clinical trial is to learn if telehealth-based Cognitive Behavioral Therapy for Insomnia (CBT-I) adapted for Ulcerative Colitis (UC) works to treat insomnia in adults with UC. The main questions it aims to answer are:

* Is telehealth-based CBT-I adapted for UC feasible and acceptable to participants? * Does CBT-I for UC impact insomnia severity and sleep continuity?

Participants will:

* Answer questionnaires online before and after treatment * Complete an online daily sleep diary before, during, and after treatment * Participate in 5 telehealth treatment visits over 7-8 weeks * Participate in 5-10-minute phone calls between treatment visits

Eligibility criteria

Qualifiers

Active UC based on PRUCSI

Insomnia Severity Index score > 8 and SOL or WASO > 30 minutes

Stability of sleep & UC meds for > 3 months

Access to internet or cell phone service sufficient for telehealth

Disqualifiers

PHQ-9 depression score > 15

GAD-7 anxiety score > 15

Unstable major psychiatric condition (e.g., bipolar disorder, psychotic disorder)

Current alcohol or substance abuse

Trial design

Treatments tested in this trial

  • CBT-I UC

Treatment groups

20 Participants
are divided into 1 treatment group